News Search Results
Apr 09, 2026, 20:00 ET AI Pioneer and Nobel Laureate Geoffrey Hinton Joins Human Longevity, Inc. Scientific Advisory Board
forward to contributing to this important mission."About Human Longevity, Inc.Founded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan. Through its flagship
More news about: Human Longevity Inc.
Apr 09, 2026, 18:31 ET CleanSpace to Unveil Nation's Largest Working Cleanroom on a Tradeshow Floor at INTERPHEX Global, April 21-23, 2026
immersive manufacturing environment. Designed as a complete cleanroom suite, the structure allows attendees to experience real-world pharmaceutical and biotechnology production in action.Key Features Include:ISO-classified manufacturing space with gowning and process areasFully
More news about: CleanSpace Modular, LLC
Apr 09, 2026, 17:45 ET ImmunityBio, Inc. (IBRX) Facing Securities Class Action Amid FDA Warning Regarding Unsupported Cancer Treatment Claims, $2 Billion Market Capitalization Wiped Out -- Hagens Berman
[email protected], Inc. (IBRX) Securities Class Action: ImmunityBio is a biotechnology company focused on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system
More news about: Hagens Berman Sobol Shapiro LLP
Apr 09, 2026, 16:05 ET Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
QC, April 9, 2026 /PRNewswire/ -- Congruence Therapeutics, a clinical-stage, computationally-driven biotechnology company building a unique pipeline of pharmacological correctors for diseases of protein misfolding, including MC4R-deficient (MC4R-d) genetic obesity,
More news about: Congruence Therapeutics
Apr 09, 2026, 09:52 ET Global Times: Feeling the city of the future: In Xiong'an, innovation is born and comes alive
Zhongguancun Science Park in Xiong'an, with a managed area of 207,000 square meters, focuses on cutting-edge sectors including AI, digital technology, biotechnology, and the low-altitude economy.Its nine themed buildings follow a "one building, one industry, one ecosystem" model, housing 269 technology
More news about: Global Times
Apr 09, 2026, 09:45 ET Medical Knowledge Group Appoints Christie Mealo as Chief AI Officer
April 9, 2026 /PRNewswire/ -- Medical Knowledge Group (MKG), a strategic commercialization partner to pharmaceutical and biotechnology innovators, today announced the appointment of Christie Mealo as Chief AI Officer.
More news about: Medical Knowledge Group
Apr 09, 2026, 09:05 ET Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that Dr. Amit Kumar, Anixa's Chairman and CEO, will participate in the
More news about: Anixa Biosciences, Inc.
Apr 09, 2026, 09:03 ET Alpheus Medical Initiates Phase 2b Trial of Investigational Therapy for Newly Diagnosed Glioblastoma
Alpheus Medical, Inc., a private, clinical-stage biotechnology company, today announced the initiation of its Phase 2b randomized controlled trial in newly diagnosed glioblastoma (nGBM) with 10 patients enrolled
More news about: Alpheus Medical
Apr 09, 2026, 09:00 ET NEXTBIOMEDICAL Secures Exclusive Distribution Agreement for Nexsphere-F™ in Japan
Unlike many biotechnology companies that generate revenue through technology transfer and royalties, NEXTBIOMEDICAL differentiates itself by exporting finished medical devices
More news about: NEXTBIOMEDICAL CO., LTD.
Apr 09, 2026, 08:36 ET Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline
HOUSTON, April 9, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new category of antivirals engineered to work across multiple viruses, today highlighted
More news about: Decoy Therapeutics, Inc
Apr 09, 2026, 08:15 ET Mimulus and GenScript Partner to Scale the World's First Zero-Watt Molecular Archive Infrastructure for the AI Era
as Mimulus targets full hyperscale production by the end of the decade.About Mimulus CorpMimulus Corp is a venture-backed biotechnology company architecting the world's first economically sustainable and physically permanent archival infrastructure for the age of AI. Through its
More news about: Mimulus Corp
Apr 09, 2026, 08:03 ET MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace.Safe HarborThis press
More news about: Nordic Pharma
Apr 09, 2026, 08:03 ET MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS
Group B.V., is partnered with well-established global biopharmaceutical companies and is uniquely positioned to leverage its expertise in bringing biotechnology derived medicines, sterile manufacturing and other state-of-the-art technologies to the marketplace.Safe HarborThis press
More news about: Nordic Pharma
Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
leaders—to co-create cutting-edge solutions that redefine service excellence. Guided by its mission to Make People and Nature Healthier Through Biotechnology, GenScript has become a trusted global partner with a team of 6,100+ employees, supporting over 200,000 customers across 100+ countries and
More news about: GenScript Biotech Corporation
Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
leaders—to co-create cutting-edge solutions that redefine service excellence. Guided by its mission to Make People and Nature Healthier Through Biotechnology, GenScript has become a trusted global partner with a team of 6,100+ employees, supporting over 200,000 customers across 100+ countries and
More news about: GenScript Biotech Corporation
Apr 09, 2026, 08:00 ET Deck Bio Launches Multi-Target T Cell Engager Platform for Solid Tumors, With Preclinical Data to be Presented at AACR 2026
Emerging biotechnology company advancing multi-pMHC targeted T cell engagers to addresstumor heterogeneity and resistanceDifferentiated approach integrates proprietary T cell receptor (TCR) specificity engineering andstabilization technologies
More news about: Deck Bio, Inc.
Apr 09, 2026, 07:00 ET AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
NATICK, Mass., April 9, 2026 /PRNewswire/ -- AllRock Bio, Inc., a clinical-stage biotechnology company focused on advancing impactful therapies for cardiopulmonary and fibrotic diseases, today announced the dosing of the first patients in
More news about: AllRock Bio
Apr 09, 2026, 07:00 ET Deerfield Group Names Bill Veltre as Chief Media Officer
GroupDeerfield Group is a full-service integrated marketing, communications, and media agency providing innovative solutions for pharmaceutical, biotechnology, health tech, and consumer health companies. Deerfield's solutions are designed to meet the unique needs of healthcare organizations at all stages
More news about: Deerfield Group
Apr 09, 2026, 06:45 ET Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Apr 09, 2026, 06:30 ET Immunic to Participate in Scientific and Medical Conferences in April
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following scientific and
More news about: Immunic, Inc.
Apr 09, 2026, 05:00 ET Hamilton Dissolved Oxygen Sensors Achieve North American Ex Approval for Hazardous Environments
coverage to North America.By extending its sensor portfolio into hazardous environments, Hamilton continues to support customers across biotechnology, chemical processing, and industrial manufacturing with reliable process analytics designed for demanding applications.About
More news about: Hamilton Company
Apr 09, 2026, 03:53 ET Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts for 33.21% Share, with Asia-Pacific as the Fastest-Growing Region, Says Mordor Intelligence
advancements in genetic engineering, increasing demand for bio-based products, and expanding applications across healthcare, agriculture, and industrial biotechnology. The market is gaining momentum as organizations worldwide leverage synthetic biology to design and engineer biological systems for improved efficiency,
More news about: Mordor Intelligence Private Limited
Apr 09, 2026, 02:42 ET Global Fine Chemicals Market Trends 2026-2036: Regional Growth Strategies from Sumitomo Chemical to IPCA Laboratories | Future Market Insights, Inc.
partnerships and outsourcing modelsLocalization strategies in emerging economiesCompanies investing in digital GMP compliance, biotechnology integration, and sustainable infrastructure will be best positioned to capture long-term value.ConclusionThe global fine chemicals
More news about: Future Market Insights
Apr 08, 2026, 11:12 ET INVESTOR DEADLINE: ImmunityBio, Inc. (IBRX) Investors with Substantial Losses Have Opportunity to Lead the ImmunityBio Class Action Lawsuit
[email protected] ALLEGATIONS: ImmunityBio is a biotechnology company that focuses on innovating, developing, and commercializing next-generation immunotherapies. According to the complaint, ImmunityBio's
More news about: Robbins Geller Rudman & Dowd LLP
Apr 08, 2026, 10:06 ET Lupin Announces Approval of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.